Vaxcyte Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +165,820.0% | +18.8% | +14.0% | +146.0% | +173.4% | +7.6% | +55.8% | +56.9% | |
| – | +191,951.3% | +58.2% | +358.6% | +97.4% | +120.4% | +106.2% | +74.0% | +63.7% | |
| – | – | – | – | +106.8% | +153.1% | – | – | – | |
| – | +189,400.0% | +106.2% | +802.5% | -204.9% | – | +538.5% | -167.5% | – | |
| – | +145,071.8% | -32.6% | -3.3% | +467.5% | -10.9% | +1,062.1% | -67.0% | -38.9% | |
| – | +158,771.0% | -32.6% | -7.5% | +19,113.4% | – | -1,136.8% | +159.4% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +41.8% | -31.3% | -99.1% | +137.4% | +16.3% | +97.3% | – | – | |
| – | +50.5% | -1.8% | -78.1% | -100.0% | – | – | – | – | |
| – | +141,695.3% | -33.2% | +801.8% | -95.3% | +4,741.2% | -25.7% | +282.7% | -99.9% | |
| – | +107,715.0% | -123.8% | – | -196.7% | – | -157.1% | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.